Stay updated on MRTX849 Pharmacokinetics & Safety Clinical Trial
Sign up to get notified when there's something new on the MRTX849 Pharmacokinetics & Safety Clinical Trial page.

Latest updates to the MRTX849 Pharmacokinetics & Safety Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has been updated to reflect a new version (v2.15.0) and the removal of detailed study information regarding the pharmacokinetics and safety of MRTX849 in Chinese patients with advanced solid tumors with KRAS G12C mutation.SummaryDifference36%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check88 days agoChange DetectedThe page now includes a notice about heavy traffic affecting NLM-NCBI services and products, along with updated information regarding the status of Zai Lab, which is now verified as active but not recruiting.SummaryDifference2%
Stay in the know with updates to MRTX849 Pharmacokinetics & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MRTX849 Pharmacokinetics & Safety Clinical Trial page.